Stay updated on CT-P13 SubQ in Active Crohn's: LIBERTY-CD Clinical Trial
Sign up to get notified when there's something new on the CT-P13 SubQ in Active Crohn's: LIBERTY-CD Clinical Trial page.

Latest updates to the CT-P13 SubQ in Active Crohn's: LIBERTY-CD Clinical Trial page
- Check7 days agoChange DetectedThe page now presents the full record for the completed Phase 3 LIBERTY-CD Crohn’s disease trial, including its design, eligibility, outcomes, locations, publications, and study documents, instead of a 403 error page.SummaryDifference59%

- Check14 days agoChange DetectedThe footer revision identifier changes from v3.7.2 to v3.8.0, while the study page continues to display a 403 error.SummaryDifference0.2%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedA site-wide NIH announcement about updated terminology appears above the page, and the footer revision label changes from v3.7.1 to v3.7.2. The study record itself still displays a 403 Forbidden error.SummaryDifference1%

- Check42 days agoChange DetectedThe ClinicalTrials.gov page continues to display a 403 Forbidden error, with the footer revision updated from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check56 days agoChange DetectedThe page now displays a 403 Forbidden error screen with minimal content and navigation, instead of the study details. It reflects restricted access to view the record rather than changes to the study itself.SummaryDifference18%

- Check63 days agoChange DetectedRevision tag updated from v3.6.6 to v3.7.0, signaling a minor update to the page’s backend or content management without changing the study information.SummaryDifference0.0%

Stay in the know with updates to CT-P13 SubQ in Active Crohn's: LIBERTY-CD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CT-P13 SubQ in Active Crohn's: LIBERTY-CD Clinical Trial page.